To further investigate the role of PRC1 in pancreatic cancer, a genetic mouse model, such as Kras (G12D) with Tp53 mutations (KPC model), incorporating PRC1 alterations could be valuable for confirming the involvement of PRC1 in the disease’s progression. This evidence concerns the gene TP53 and familial pancreatic carcinoma.